About BioSig
BioSig is a company based in Westport (United States) founded in 2009 by Ken Londoner.. BioSig has raised $8.72 million across 46 funding rounds from investors including Millennium Management and Mayo Clinic Business Accelerator. The company has 64 employees as of December 31, 2022. BioSig offers products and services including PURE EP Platform and Signal Processing Technology.
- Headquarter Westport, United States
- Employees 64 as on 31 Dec, 2022
- Founders Ken Londoner
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biosig Technologies, Inc.
-
Annual Revenue
$40 K122as on Dec 31, 2024
-
Net Profit
$-10.33 M-3043as on Dec 31, 2024
-
EBITDA
$-12.67 M55as on Dec 31, 2024
-
Total Equity Funding
$8.72 M (USD)
in 46 rounds
-
Latest Funding Round
$819 K (USD), Post-IPO
Mar 05, 2025
-
Investors
Millennium Management
& 1 more
-
Employee Count
64
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BioSig
BioSig is a publicly listed company on the NASDAQ with ticker symbol BSGM in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of BioSig
BioSig offers a comprehensive portfolio of products and services, including PURE EP Platform and Signal Processing Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A platform that is employed for capturing intracardiac signals with high clarity to aid in arrhythmia treatment procedures
Technology that is used for enhancing cardiac signal visualization and supporting advancements in electrophysiology
Unlock access to complete
Unlock access to complete
Advisor Team
6 people
Leadership Team
4 people
Software Development Team
1 people
Clinical Team
1 people
Unlock access to complete
Funding Insights of BioSig
BioSig has successfully raised a total of $8.72M across 46 strategic funding rounds. The most recent funding activity was a Post-IPO round of $819 thousand completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 46
- Last Round Post-IPO — $818,998
-
First Round
First Round
(19 Sep 2011)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Post-IPO - BioSig | Valuation |
investors |
|
| May, 2024 | Amount | Post-IPO - BioSig | Valuation |
investors |
|
| Jan, 2024 | Amount | Post-IPO - BioSig | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BioSig
BioSig has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Millennium Management and Mayo Clinic Business Accelerator. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare startups are accelerated by Mayo Clinic Business Accelerator.
|
Founded Year | Domain | Location | |
|
Diversified investment management services are provided from New York.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BioSig
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BioSig
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biosig Comparisons
Competitors of BioSig
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biosig
Frequently Asked Questions about BioSig
When was BioSig founded?
BioSig was founded in 2009 and raised its 1st funding round 2 years after it was founded.
Where is BioSig located?
BioSig is headquartered in Westport, United States.
Is BioSig a funded company?
BioSig is a funded company, having raised a total of $8.72M across 46 funding rounds to date. The company's 1st funding round was a Post-IPO of $1.48M, raised on Sep 19, 2011.
How many employees does BioSig have?
As of Dec 31, 2022, the latest employee count at BioSig is 64.
What is the annual revenue of BioSig?
Annual revenue of BioSig is $40K as on Dec 31, 2024.
What does BioSig do?
BioSig was founded in 2009 by Ken Londoner in Westport, United States. Operations are centered on the development and manufacturing of signal processing devices tailored for medical applications. The company serves the healthcare industry by providing technology that enhances signal analysis in diagnostic and therapeutic contexts. Focus is placed on precision engineering to support medical professionals across the United States and beyond.
What products or services does BioSig offer?
BioSig offers PURE EP Platform and Signal Processing Technology.
Is BioSig publicly traded?
Yes, BioSig is publicly traded on NASDAQ under the ticker symbol BSGM.
Who are BioSig's investors?
BioSig has 2 investors. Key investors include Millennium Management, and Mayo Clinic Business Accelerator.
What is BioSig's ticker symbol?
The ticker symbol of BioSig is BSGM on NASDAQ.